Key result
Higher pre-ECMO lactate (HR 1.023) and lower post-ECMO LVEF (HR 0.928) were significantly associated with increased in-hospital mortality in children with acute fulminant myocarditis on VA-ECMO.
Why the study?
Factors associated with in-hospital mortality in children with acute fulminant myocarditis on VA-ECMO needed to be analyzed.
Cohort (n=33)
Yes
Hazard Ratio: 1.023 (95% CI 1.007–1.04)
p-value: p=0.005
In children with acute fulminant myocarditis on VA-ECMO, pre-ECMO lactate >79.8 mg/dL and post-ECMO LVEF <39% are strong predictors of in-hospital mortality, suggesting these thresholds could guide decisions for LVAD or urgent heart transplantation.
Pre-ECMO lactate and post-ECMO LVEF may predict mortality in pediatric fulminant myocarditis on VA-ECMO; leaves open prospective validation.
Aim: To analyze the factors associated with in-hospital mortality of children with acute fulminant myocarditis on venoarterial extracorporeal membrane oxygenation (VA-ECMO). Methods: This was a retrospective cohort study using chart reviews of patients diagnosed with acute fulminant myocarditis at the pediatric intensive care unit of two tertiary medical centers between January 1, 2005 and December 31, 2017. The inclusion criteria for this study were: 1) age from 1 month to 18 years; 2) diagnosed with acute myocarditis; 3) cardiogenic shock and need vasoactive-inotropic score ≧20 within 48 hours after the use of vasoactive-inotropic agents; and 4) the need for ECMO placement. Results Thirty-three children with acute fulminant myocarditis who needed ECMO were included. Clinical parameters were retrospectively reviewed. The overall survival rate was 69.6%. Higher levels of pre-ECMO troponin-I and pre-ECMO lactate, and lower post-ECMO left ventricular ejection fraction (LVEF) were significantly associated with in-hospital mortality in univariate analysis. Only higher pre-ECMO lactate and lower post-ECMO LVEF remained as predictors for in-hospital mortality in multivariate analysis. The areas under the curve of pre-ECMO lactate and post-ECMO LVEF in predicting survival were 0.84 (95% CI, 0.697-0.999, p=0.002) and 0.824 (95% CI, 0.704-0.996, p=0.02), respectively. A pre-ECMO lactate level of 79.8 mmol/L and post-ECMO LVEF of 39% were appropriate cutoff points to predict mortality. Conclusion Pre-ECMO lactate level was associated with mortality in children with acute fulminant myocarditis, with an optimal cutoff value of 79.8 mmol/L. After VA-ECMO implantation, post-ECMO LVEF was associated with mortality, with an optimal cutoff value of 39%. The use of LVADs or urgent heart transplantation should be considered if the post-ECMO LVEF does not improve.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) conducted a cohort in Acute fulminant myocarditis on VA-ECMO (n=33). Pre-ECMO lactate and post-ECMO LVEF was evaluated on In-hospital mortality (HR 1.023, 95% CI 1.007-1.04, p=0.005). Higher pre-ECMO lactate (HR 1.023) and lower post-ECMO LVEF (HR 0.928) were significantly associated with increased in-hospital mortality in children with acute fulminant myocarditis on VA-ECMO.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: